APA (7th ed.) Citation

Sugi, T., Mita, M., Yasu, T., Kubo, K., Kushi, R., Hanai, H., . . . Hagihara, M. (2022). Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash. Journal of Clinical Pharmacy and Therapeutics, 47(4), 477-482. https://doi.org/10.1111/jcpt.13568

Chicago Style (17th ed.) Citation

Sugi, Tomiyuki, et al. "Preceding Bortezomib Administration for a Certain Period Reduces the Risk of Lenalidomide‐induced Skin Rash." Journal of Clinical Pharmacy and Therapeutics 47, no. 4 (2022): 477-482. https://doi.org/10.1111/jcpt.13568.

MLA (9th ed.) Citation

Sugi, Tomiyuki, et al. "Preceding Bortezomib Administration for a Certain Period Reduces the Risk of Lenalidomide‐induced Skin Rash." Journal of Clinical Pharmacy and Therapeutics, vol. 47, no. 4, 2022, pp. 477-482, https://doi.org/10.1111/jcpt.13568.